Lobbying

Halomd's latest lobbying report covers Q2 2026, at $460K. The four quarters Q4 2025–Q3 2026 total $1.3M. Its first report covers Q4 2025; the issues it reports most are Health Issues and Medicare/Medicaid.

Halomd

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$1.3M
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2025
The first quarter a report named it

Lobbying by quarter

Halomd lobbying by quarter
Halomd lobbying by quarter
QuarterAmountReports
Q4 2025$400K2
Q1 2026$460K2
Q2 2026$460K2
Q3 2026$00

By issue

  • Health issues$660K · 6 reports
  • Medicare and Medicaid$660K · 6 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES6 reports
  • SENATE6 reports
  • Health & Human Services, Dept of (HHS)3 reports
  • Labor, Dept of (DOL)1 reports

Firms it paid

Firm
In-houseHalomd$990K3 quarters
Foley & Lardner$330K3 quarters

Former officials lobbying for it

Former position
JARED RIFISLegislative Correspondent, Legislative Aide; Legislative Assistant: Sen. Harry ReidQ2 2026
JENNIFER FITZGERALD WALSHAA; Deputy COS, COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Fazio; Staff Asst, Program Dir, EA: House Democratic CaucusQ2 2026
JOHN STROMSenior Counsel - U.S. House Cmte on Energy & Commerce; Counsel - U.S. Senate Cmte on Health, Education, Labor, and Pensions; Associate General Counsel - U.S. Dept of Health and Human Services; Senior Counsel - U.S. House Cmte on Natural ResourcesQ2 2026
KATIE SCHOETTLERCommunications Director & Senior Advisor - U.S. Senator Steve Daines; Press Secretary - House Committee on Natural ResourcesQ2 2026
PATRICK VELLIKYLegislative Director, Congressman James B. Renacci (Feb 2014 - Sept 2015) Legislative Assistant, Congressman James B. Renacci (Jan 2011 - Oct 2011) Deputy Legislative Director, Senator Arlen Specter (April 2009 - Jan 2011)Q2 2026

Lobbying reports

Filed by
09/17for Q3Holland & KnightUnder $5,000
07/20for Q2In-house$350K
07/19for Q2Foley & Lardner$110K
04/22for Q1In-house$350K
04/20for Q1Foley & Lardner$110K
01/19for Q4 2025Foley & Lardner$110K
01/12for Q4 2025In-house$290K
25/11/06for Q4 2025In-houseUnder $5,000
25/10/20for Q4 2025Foley & LardnerUnder $5,000